F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 34.25 SEK -1.72% Market Closed
Market Cap: 466.5m SEK
Have any thoughts about
Fluoguide AS?
Write Note

Fluoguide AS
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluoguide AS
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluoguide AS
STO:FLUO
Interest Income Expense
kr47k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Interest Income Expense
kr1.6B
CAGR 3-Years
643%
CAGR 5-Years
53%
CAGR 10-Years
65%
Zealand Pharma A/S
CSE:ZEAL
Interest Income Expense
kr119.1m
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
45%
Ascendis Pharma A/S
NASDAQ:ASND
Interest Income Expense
-€126.9m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
-73%
B
Bavarian Nordic A/S
CSE:BAVA
Interest Income Expense
kr93.2m
CAGR 3-Years
N/A
CAGR 5-Years
56%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Interest Income Expense
kr558k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Fluoguide AS
Glance View

Market Cap
425m SEK
Industry
Biotechnology

FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.

FLUO Intrinsic Value
38.82 SEK
Undervaluation 12%
Intrinsic Value
Price
F

See Also

What is Fluoguide AS's Interest Income Expense?
Interest Income Expense
47k DKK

Based on the financial report for Dec 31, 2023, Fluoguide AS's Interest Income Expense amounts to 47k DKK.

Back to Top